Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: An in vivo proof-of-concept study
- 28 February 2011
- journal article
- research article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 150 (1), 102-110
- https://doi.org/10.1016/j.jconrel.2010.10.036
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre studyThe Lancet Oncology, 2010
- A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imagingEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Fast high‐resolution T1 mapping using inversion‐recovery look‐locker echo‐planar imaging at steady state: Optimization for accuracy and reliabilityMagnetic Resonance in Medicine, 2009
- Hyperthermia adds to chemotherapyEuropean Journal of Cancer, 2008
- MR thermometryJournal of Magnetic Resonance Imaging, 2008
- In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Pulsed-High Intensity Focused Ultrasound and Low Temperature–Sensitive Liposomes for Enhanced Targeted Drug Delivery and Antitumor EffectClinical Cancer Research, 2007
- Simultaneous monitoring of temperature and T1: Methods and preliminary results of application to drug delivery using thermosensitive liposomesMagnetic Resonance in Medicine, 2005
- Randomized Trial of Hyperthermia and Radiation for Superficial TumorsJournal of Clinical Oncology, 2005
- Liposomes as MR contrast agents: Pros and consMagnetic Resonance in Medicine, 1991